Evidence map›Paper›PMID 39076679›Full record

ArticleGynecologic oncology reports2024

Recurrent malignant struma ovarii presenting as peritoneal carcinomatosis in the setting of an intact thyroid: A case report and review of the literature.

Morgan Brown, Paulina Haight, Matthew Ringel, John Phay, Ashwini Esnakula, Jennifer Vazzano, Casey Cosgrove

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Morgan BrownThe Ohio State University Wexner Medical Center, Department of Obstetrics and Gynecology, United States.
Paulina HaightThe James Comprehensive Cancer Center at The Ohio State University, Department of Gynecologic Oncology, United States.
Matthew RingelThe James Comprehensive Cancer Center at The Ohio State University, Department of Molecular Medicine and Therapeutics, United States.
John PhayThe James Comprehensive Cancer Center at The Ohio State University, Department of Surgical Oncology, United States.
Ashwini EsnakulaThe Ohio State University Wexner Medical Center, Department of Pathology, United States.
Jennifer VazzanoThe Ohio State University Wexner Medical Center, Department of Pathology, United States.
Casey CosgroveThe James Comprehensive Cancer Center at The Ohio State University, Department of Gynecologic Oncology, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant struma ovarii is an exceedingly rare pathology with a paucity of established criteria regarding management and surveillance with recommendations largely based on case reports and retrospective data. Many authors have supported stratification of malignant struma ovarii into low vs high-risk disease with more conservative management reserved for those deemed low-risk. Here we present a unique case of recurrent metastatic malignant struma ovarii after surveillance was undertaken in the setting of initially low-risk disease.

Indexed as

Germ cell tumorsMalignant struma ovariiSerial thyroglobulin

Identifiers

PMID39076679
PMCPMC11284547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.